Recall of Nicotine Pouch Product Zyn by Canadian Government

Regulations by 2FIRSTS.ai
Jun.13.2024
Recall of Nicotine Pouch Product Zyn by Canadian Government
Canada issues recall for popular nicotine pouch Zyn by Philip Morris over lack of authorization, impacting various retailers.

According to a report by Canadian media CTV News on June 12th, the Canadian government has issued a recall order for the nicotine pouch product Zyn, which is owned by Philip Morris. It is worth noting that Zyn nicotine pouches have recently gained popularity as smoking alternatives. The government stated that these products have not been authorized for sale domestically.

 

This recall impacts retailers selling various flavors of nicotine pouches, including apple mint, black cherry, citrus, peppermint, original, espresso, spearmint, and Bellini (named after the Italian cocktail). Most of these flavors contain 3mg of nicotine per pouch, with the spearmint flavor containing 1.5mg of nicotine. According to data from Nicorette, a typical cigarette contains between 6 to 12.6mg of nicotine each.

 

Earlier this year, nicotine pouches captured public attention. Canadian government officials and parents expressed concerns, believing that these various flavored products would appeal to adolescents. British Columbia Health Minister Adrian Dix pointed out that because these products are classified as smoking cessation aids, minors can often legally purchase them.

 

The majority leader of the United States Senate, Chuck Schumer, has issued a warning to parents.

 

Because these nicotine pouches seem to target young children - teenagers, and even younger children, and attract them through social media.

 

A spokesperson for Philip Morris responded by saying that the marketing of Zyn is "strictly" targeted towards individuals aged 21 and older.

 

Zyn has been approved for sale in the United States. PMI announced in February of this year that the shipment volume of Zyn is expected to be around 350 million packets by 2023, which is a 62% increase from the previous year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai
Spanish Anti-Tobacco Group Urges 10-Year “Cooling-Off” Ban on Ex-Officials Working for Tobacco Industry
Spanish Anti-Tobacco Group Urges 10-Year “Cooling-Off” Ban on Ex-Officials Working for Tobacco Industry
Spanish advocacy group Nofumadores.org has called for urgent reforms to Spain’s conflict-of-interest rules to bar politicians and senior civil servants from taking jobs in the tobacco industry for 10 years after leaving office. The appeal follows a series of hires by Philip Morris, Japan Tobacco International (JTI) and distributor Logista that the group says risk undermining ongoing anti-tobacco legislation. The Health Ministry, led by Mónica García, aims to expand smoke-free spaces, raise tobac
Sep.08
Vapesourcing, a leading U.S. vape retailer, has announced it will no longer supply flavored nicotine products to California and Massachusetts.
Vapesourcing, a leading U.S. vape retailer, has announced it will no longer supply flavored nicotine products to California and Massachusetts.
Due to local regulations, leading U.S. vape retailer Vape Sourcing has stopped shipping flavored nicotine products to California and Massachusetts. This is because California is implementing a "flavor ban," while Massachusetts already banned flavored tobacco and vapes in 2019. Customers in these states can still buy unflavored or non-nicotine products.
Aug.22 by 2FIRSTS.ai
UK Retailer VPZ Slams Government’s “Double Standards”: Deputy PM Vapes While Policy Pushes Against Harm Reduction
UK Retailer VPZ Slams Government’s “Double Standards”: Deputy PM Vapes While Policy Pushes Against Harm Reduction
UK vape retailer VPZ accused the government of hypocrisy in its vaping policies. On one hand, Deputy Prime Minister Angela Rayner was photographed using a vape as a smoking alternative; on the other, the Labour Party is pushing for stricter restrictions on vape flavors, packaging, and marketing. VPZ warned that such measures may backfire, hindering adult smokers from quitting and fueling the black market.
Aug.28 by 2FIRSTS.ai
Ministry of Finance of Malaysia: Total tobacco tax revenue reaches $3.3 billion since 2021, with e-cigarettes accounting for only 2%
Ministry of Finance of Malaysia: Total tobacco tax revenue reaches $3.3 billion since 2021, with e-cigarettes accounting for only 2%
Malaysia's tobacco tax revenue surges, contributing over RM15.3 billion (approximately $3.3 billion) from 2021 to 2025, with e-cigarette tax revenue hitting a record high, reflecting clear consumption trends.
Aug.26 by 2FIRSTS.ai
Singapore arrests 195 in nationwide crackdown on e-cigarette violations, seizes dangerous 'Kpods' containing anesthesia substance
Singapore arrests 195 in nationwide crackdown on e-cigarette violations, seizes dangerous 'Kpods' containing anesthesia substance
Singapore recently launched a nationwide operation, arresting 195 individuals for e-cigarette violations and uncovering “Kpods” e-cigarettes containing dangerous substances, which has raised health concerns.
Sep.01 by 2FIRSTS.ai